Drop Bio Health’s biomarker platform combines digital data collection with a broad combination of known and emerging proteomic biomarkers from conventional or remotely collected blood samples.
We help researchers to generate high quality data from small and large cohorts to accelerate academic and clinical research using custom and pre-configured Luminex multiplex assays.
Timely. Affordable. Reliable. Local.
Profile each participant using Drop Bio Health’s biomarker analysis platform for a holistic, longitudinal molecular understanding of health and disease. Reach a broader population with our Home Blood Sample Collection capabilities.
Enrich your biobank with in-depth proteomic analysis to advance health research and benefit public health.
Use Drop Bio Health’s biomarker platform to collect context-rich lifestyle data combined with proteomic data to understand the effects of interventions on disease risk and progression.
Generate robust data from small cohorts or establish longitudinal investigations that securely collect lifestyle data (using validated digital surveys) and combine with blood biomarkers that enables you to put your findings into context.
Use our Home Blood Sample Collection Kit (Registered Medical Device ARTG ID:371291) to conveniently reach more participants and collect samples remotely without the need for a trained phlebotomist:
Use custom or pre-configured Luminex multiplex assays for:
Drop Bio Health’s multiplex immunoassay has been accredited by Australian Laboratory Accreditation Body (ALAB, Accreditation criteria ISO/IEC 17025, accreditation number 22-3767).
If you would like to know more about how our research services can assist with your project, please reach out to our research team using the form below:
In the spirit of reconciliation Drop Bio Health acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.